Not Yet Recruiting
A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC
NCT06632405
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
Not specified